Case study about influenza virus

Are you making cell-based vaccines and looking for a way to boost productivity?

Cell-based vaccine manufacturing, using mammalian cells to grow flu viruses instead of fertilized hen’s eggs, is becoming increasingly popular. This type of vaccine can be produced faster and offers better coverage against flu infection than the eggs-based vaccine.

To improve the biomanufacturing in mammalian cells, we tested our recombinant insulin in the cell culture media of HEK293 cells producing influenza virus. We found that adding insulin to the feeding media of HEK293 cells boosts the production of the influenza virus up to 2-fold, compared to the media without insulin.

Read this case study to find out more about the use of insulin in the manufacturing of cell-based vaccines.